The Hospital That Decided One Country Wasn’t Enough

From One Cardiac Ward to a Caribbean Tax-Friendly Empire

There’s a version of this story that starts with Dr. Devi Shetty, a cardiac surgeon, looking at the cost of open-heart surgery in India and asking a genuinely radical question: what if it didn’t have to cost that much? The company was incorporated in 2000, misspelled, renamed correctly in 2008 (even the founders needed a spellcheck), and converted to a public company in time for a listing that gave retail investors access to one of the cleanest healthcare balance sheets in India.

By FY25, the original noble mission — “Healthcare for All” — has evolved into something more sophisticated: a 40-facility network across India, Cayman Islands, and now UK (consolidated in Q3 FY26). The company treats complex cardiac cases, runs dialysis centres, performs cancer surgeries, and now underwrites health insurance in the Caribbean. Not bad for a business that started by wanting to make heart surgery affordable.

The numbers are hard to argue with. Standalone revenues grew from ₹1,076 crore in FY14 to ₹3,590 crore in FY25 — a decade-long compounding machine. PAT grew from ₹36 crore to ₹431 crore over the same period, with only one meaningful interruption: FY21, when COVID sent revenues to ₹1,655 crore and PAT to ₹-79 crore. The recovery was so swift and complete that FY21 now looks like a brief blip in an otherwise vertical earnings chart.

The most recent disclosed quarter — Q3 FY26 (December 2025) — posted consolidated operating revenue of ₹21,512 million. UK numbers were consolidated for the first time that quarter, per management’s commitment from Q2 FY26. A new north India subsidiary was incorporated in January 2026. Three simultaneous geographic bets, running in parallel with Cayman insurance that just started generating (and losing) money. If this company was a patient, the doctor would say: vitals are excellent, but we’re scheduling a lot of procedures at once.

Beds, Blades, Billing, and Now — Insurance?

Imagine a factory. Instead of making widgets, it makes people healthy. The inputs are beds, doctors, nurses, operating theatres, ICUs, and extremely expensive diagnostic equipment. The output is treated patients who pay — either directly, through insurance, via government schemes, or as international medical tourists. That’s a hospital. Simple in theory; one of the most complicated businesses to run in practice.

Narayana runs a multi-specialty and super-specialty chain. Cardiac surgery is the founding speciality — Dr. Shetty famously performed affordable heart surgeries by applying assembly-line efficiency principles to the operating theatre. But over time the portfolio expanded: oncology, neurology, orthopaedics, renal care, dialysis, mother and child care, eye care. The FY25 investor deck breaks revenue into inpatient, outpatient, consumables, and other operating revenues including teleradiology income and IT-for-healthcare services.

The payer mix is genuinely interesting: domestic walk-ins (cash), insured patients (corporate/retail insurance), government scheme patients (Ayushman Bharat and state schemes), and international patients. Each segment has different realisation, different collection timelines, and different receivable risk. The company also has a negative cash conversion cycle (-122 days in FY25), meaning suppliers are effectively funding the business — a structural advantage that comes from the hospital’s negotiating power with vendors.

And then there’s the new layer: Cayman Integrated Healthcare Ltd (CIHL) — a 100% step-down subsidiary that launched health insurance underwriting on July 1, 2024, with approvals from the Cayman Islands Monetary Authority. Management estimated the total Cayman insurance market at approximately USD 300-350 million. FY25 insurance segment revenue: ₹312.92 Mn. FY25 insurance segment loss: ₹250.99 Mn. Early-stage burn, they call it. Investors call it: let’s wait and watch.

Q3 FY26: The Numbers That Matter